First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System.
JACC: Case Reports(2023)
摘要
Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.).
更多查看译文
关键词
percutaneous,transcatheter valve therapy,tricuspid regurgitation,valve replacement
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要